Crossmark

Synthesis and biological evaluation of benzyloxymethyl-substituted imidazo[1,2-a]pyridines as apoptosis-inducing anticancer agents through modulation of BCL-2/Bax signaling and caspase-3 activation

Crossref DOI link: https://doi.org/10.1007/s00210-026-05638-6

Published Online: 2026-06-26

Published Print: 2026-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Arzuk, Ege

Pinar, İbrahim

Kuzu, Burak https://orcid.org/0000-0002-7305-7177
Funding

Funding for this research was provided by:

Van Yuzuncu Yil University
License Information

Text and Data Mining valid from 2026-06-26

Version of Record valid from 2026-06-26
More Information

Article History

Received: 31 May 2026

Accepted: 22 June 2026

First Online: 26 June 2026

Declarations

Clinical trial number: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below